Cargando…
Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability
Vildagliptin is a selective and potent dipeptidyl peptidase-4 inhibitor that improves glycemic control by inhibiting the degradation of both endogenous glucagon-like peptide-1 and glucose-dependent insulinotropic peptide. This article is a comprehensive review of the safety and efficacy of vildaglip...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694507/ https://www.ncbi.nlm.nih.gov/pubmed/23818788 http://dx.doi.org/10.2147/TCRM.S30071 |